|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent AGTC insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why AGTC insider buys are important for investors to follow.
Date | Insider | Price | Amount |
12-14-2018 Insider Buy |
William Aliski Director |
$3.25
CAGR »
|
$19,477.00 6,000 shares |
12-14-2018 Insider Buy |
James Rosen Director |
$3.38
CAGR »
|
$3,381.00 1,000 shares |
12-14-2018 Insider Buy |
William A. Sullivan Chief Financial Officer |
$3.33
CAGR »
|
$9,990.00 3,000 shares |
12-14-2018 Insider Buy |
Susan B. Washer President and CEO |
$3.34
CAGR »
|
$7,949.20 2,380 shares |
9-20-2016 Insider Buy |
Stephen W. Potter See Remarks |
$8.89
CAGR »
|
$12,446.00 1,400 shares |
9-22-2016 Insider Buy |
Mark S. Shearman Chief Scientific Officer |
$8.87
CAGR »
|
$26,601.50 3,000 shares |
9-19-2016 Insider Buy |
Lawrence E. Bullock Chief Financial Officer |
$8.75
CAGR »
|
$87,500.00 10,000 shares |
4-1-2014 Insider Buy |
Plc Glaxosmithkline >10% Owner |
$12.00
CAGR »
|
$1,245,144.00 103,762 shares |
4-1-2014 Insider Buy |
Alta Partners VIII, L.P. >10% Owner |
$12.00
CAGR »
|
$1,867,740.00 155,645 shares |
4-1-2014 Insider Buy |
Jill Carroll Director and >10% Owner |
$12.00
CAGR »
|
$1,245,144.00 103,762 shares |
4-1-2014 Insider Buy |
MedImmune Ventures, Inc. >10% Owner |
$12.00
CAGR »
|
$908,820.00 75,735 shares |
4-1-2014 Insider Buy |
Arnold L. Oronsky Director and >10% Owner |
$12.00
CAGR »
|
$908,832.00 75,736 shares |
4-1-2014 Insider Buy |
Samuel Wu Director and >10% Owner |
$12.00
CAGR »
|
$908,820.00 75,735 shares |
4-1-2014 Insider Buy |
Partners Viii LP Interwest >10% Owner |
$12.00
CAGR »
|
$904,512.00 75,376 shares |
Also See: Institutional Holders of AGTC
Also See: SEC filings
Below we present the annualized performance delivered by AGTC stock since 12-14-2018 (the date of the most recent
insider purchase). The performance of the investment from the time AGTC insider buying occurred is the ultimate
test of whether insiders were right about AGTC being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/17/2018 |
|
End date: |
12/01/2022 |
|
Start price/share: |
$3.11 |
|
End price/share: |
$0.39 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-87.33% |
|
Average Annual Total Return: |
-40.66% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,266.79 |
|
Years: |
3.96 |
|
AGTC Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent AGTC insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding AGTC
|
|